ALNA Allena Pharmaceuticals Inc.

6.23
-0.12  -2%
Previous Close 6.35
Open 6.29
Price To Book 2.62
Market Cap 129677537
Shares 20,815,014
Volume 4,115
Short Ratio
Av. Daily Volume 41,892

Drug Information

Drug catalyst information is displayed when you hover over the stage bar graph.

Data from first Phase 3 trial due 2H 2019.
Reloxaliase ALLN-177 (URIROX-1)
Enteric Hyperoxaluria
Phase 2 interim data due 1H 2019 and top-line data due 2H 2019.
Reloxaliase ALLN-177 open label
Primary hyperoxaluria
Phase 3 trial initiated 4Q 2018.
Reloxaliase ALLN-177 (URIROX-2)
Enteric Hyperoxaluria